Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Share News (AVCT)

Share Price Information for Avacta Group (AVCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 40.50
Bid: 40.00
Ask: 41.00
Change: -1.90 (-4.48%)
Spread: 1.00 (2.50%)
Open: 41.50
High: 41.50
Low: 40.50
Prev. Close: 42.40
AVCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: Ten Entertainment, Emmerson chairs step down

Thu, 25th Mar 2021 15:57

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Thursday and not separately reported by Alliance News:

----------

Ten Entertainment Group PLC - Cranfield, England-based tenpin bowling operator - Nick Basing will step down as chair in September, after 6 years in the role and 12 with the company and its predecessor Essenden. Company has started the process of finding a replacement.

----------

Emmerson PLC - Khemisset potash project in northern Morocco - Mark Connelly retires as non-executive chair at general meeting, during which shareholders also approved Emmerson's move to AIM from the London Main Market, effective from Friday. Non-Executive Director James Kelly is promoted to independent non-executive chair.

----------

Ceres Power Holdings PLC - Horsham, West Sussex-based solid oxide fuel cell developer - Hires Tudor Brown as independent non-executive director, starting Thursday next week. Brown was among the founders of computer chip designer ARM Holdings PLC and served ARM as chief technology officer and chief operating officer. He is on the board of Hong Kong-listed personal computer and smart phone maker Lenovo Group Ltd.

----------

Atalaya Mining PLC - copper and silver mining in Spain - Jose Sierra will retire as an independent non-executive director on Wednesday next week, having served on the Atalaya board since 2011.

----------

Euromoney Institutional Investor PLC - London-based business media and events - Lorna Tilbian steps down as non-executive director, effective immediately, "to spend more time focusing on her other business interests".

----------

Biome Technologies PLC - Southampton, Hampshire-based biodegradable plastics and radio frequency systems - Hires Simon Herrick as non-executive director, joining immediately. Herrick is a non-executive director of London listings Ramsdens Holdings PLC and FireAngel Safety Technology Group PLC. As an executive, Herrick was chief financial officer for a number of companies, including department store chain Debenhams and Blancco Technology Group PLC. He will replace Michael Kayser as chair of the audit and remuneration committees when Kayser retires from the board at the Biome's annual general meeting on April 21.

----------

Avacta Group PLC - Wetherby, England-based developer of cancer immunotherapies - Mike Owen steps down as non-executive director, effective immediately, but remains chair of Avacta's scientific advisory board.

----------

Arrow Global Group PLC - European investor and alternative asset manager of loan portfolios - Appoints Davide Stecchi as managing director of Underwriting to lead the Arrow Capital Management underwriting team. Prior to joining Arrow, Stecchi spent 7 years at Hudson Advisors.

----------

Tirupati Graphite PLC - London-based graphite producer with operations in Madagascar and India - Strengthens its team across its three business units to support its growth. Appoints Biswal as head of the Tirupati Graphene & Mintech Research Centre. Names Sathpathy as an advisor to the company, specially focussed on application of graphene in aluminium manufacturing smelters and graphene aluminium composites development. Appoints Dash, who is also focused on graphene engineering science, to board.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
28 Jan 2020 11:57

Avacta Demonstrates Initial Proof Of Concept For Cancer Drug TMAC

Avacta Demonstrates Initial Proof Of Concept For Cancer Drug TMAC

Read more
23 Jan 2020 12:44

Affimer Unit Performance Helps Avacta Revenue Beat Market Forecasts

Affimer Unit Performance Helps Avacta Revenue Beat Market Forecasts

Read more
23 Jan 2020 10:28

Avacta doubles revenues thanks to LG Chem milestone payment

(Sharecast News) - Biotherapeutics development outfit Avacta doubled revenues in the 17-month period ended 31 December 2019 as it was boosted by an initial milestone payment from LG Chem.

Read more
21 Jan 2020 12:48

Avacta Group Hires Vectura Group CFO Fry As Non-Executive Director

Avacta Group Hires Vectura Group CFO Fry As Non-Executive Director

Read more
8 Jan 2020 15:27

Avacta Group enters joint venture with South Korea's Daewoong

(Sharecast News) - Biotherapeutics and reagents developer Avacta Group has agreed to establish a joint venture in South Korea with Daewoong Pharmaceutical, it announced on Wednesday, and to enter into a collaboration and license agreement for the joint venture to develop the next generation of cell and gene therapies, incorporating its 'Affimer' proteins to enhance the immune-modulatory effects.

Read more
8 Jan 2020 10:40

Avacta To Establish Gene Therapy Joint Venture With Daewoong Pharma

Avacta To Establish Gene Therapy Joint Venture With Daewoong Pharma

Read more
13 Nov 2019 13:51

Avacta Expands Contract With LG Chem After First Programme Completes

Avacta Expands Contract With LG Chem After First Programme Completes

Read more
13 Nov 2019 11:50

Avacta Group reports solid progress in partnership with LG Chem

(Sharecast News) - Biotherapeutics developer Avacta Group updated the market on the 'Affimer' therapeutics development partnership and license agreement with LG Chem Life Sciences, part of the South Korean LG Group, to develop Affimer therapeutics in several disease areas on Wednesday.

Read more
4 Nov 2019 18:15

Avacta Non-Executive Sam Williams Steps Down After General Meeting

Avacta Non-Executive Sam Williams Steps Down After General Meeting

Read more
18 Oct 2019 13:20

Avacta Plans GBP9 Million Fundraise; Loss Widens On Research Costs

Avacta Plans GBP9 Million Fundraise; Loss Widens On Research Costs

Read more
10 Oct 2019 11:24

Avacta Teams With ADC Therapeutics To Develop Affimer-Drug Conjugates

Avacta Teams With ADC Therapeutics To Develop Affimer-Drug Conjugates

Read more
10 Oct 2019 08:39

Avacta inks collaboration deal with ADC Therapeutics

(Sharecast News) - Biotechnology company Avacta Group has entered a collaboration and option agreement with ADC Therapeutics, which it described as a Switzerland-based clinical-stage oncology-focused biotechnology company pioneering the development of "highly potent and targeted" antibody-drug conjugates for patients suffering from haematological malignancies and solid tumours.

Read more
20 Jun 2019 10:28

Avacta partners with Selexis ahead of first-in-human trials

(Sharecast News) - Avacta Group announced on Thursday that it has partnered with life sciences company Selexis to develop the Chinese hamster ovary (CHO) cell line, which will be used to manufacture Avacta's first 'Affimer' clinical candidate for first-time-in-human clinical trials.

Read more
10 Jun 2019 10:51

Avacta Selects Candidate For First Human Trials Of Affimer Platform

LONDON (Alliance News) - Avacta Group PLC on Monday said it has selected a clinical development candidate AVA004 for first-time-in-human clinical trials of its Affimer platform.Affimer an a

Read more
3 Jun 2019 10:20

Avacta To Submit Application For TMAC Linker Testing In Tumours Study

LONDON (Alliance News) - Avacta Group PLC on Monday said it is planning to submit an application to test its TMAC linker in patients with selected solid tumours in early 2020.The company, a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.